Compare DMCC Speciality with Similar Stocks
Stock DNA
Specialty Chemicals
INR 599 Cr (Micro Cap)
23.00
40
1.05%
0.16
11.89%
2.53
Total Returns (Price + Dividend) 
Latest dividend: 2.5 per share ex-dividend date: Aug-22-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Are DMCC Speciality Chemicals Ltd latest results good or bad?
DMCC Speciality Chemicals Ltd's latest financial results for the quarter ended December 2025 present a complex picture of performance. The company reported a net profit of ₹6.17 crores, which reflects a year-on-year decline of 21.60%, contrasting sharply with the previous year's significant growth. This decline raises concerns about the sustainability of profitability despite the company's revenue growth. On the revenue front, DMCC achieved net sales of ₹150.87 crores, marking a robust year-on-year growth of 27.81%. This growth indicates strong topline momentum and positions the company for its strongest annual performance to date, as nine-month sales are already approaching the previous full-year figures. However, this revenue strength is overshadowed by significant margin compression. The operating margin fell to 9.76%, down from 15.02% in the same quarter last year, reflecting a deterioration of 526 bas...
Read full news article
DMCC Speciality Chemicals Ltd is Rated Sell
DMCC Speciality Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
DMCC Speciality Chemicals Q3 FY26: Margin Compression Clouds Revenue Growth
DMCC Speciality Chemicals Ltd., a century-old pioneer in India's chemical industry, reported mixed results for Q3 FY26 ended December 2025, with robust topline expansion overshadowed by significant margin deterioration. The micro-cap company, with a market capitalisation of ₹560.00 crores, posted a net profit of ₹6.17 crores for the quarter, marking a sequential growth of 7.30% but a concerning year-on-year decline of 21.60%. The stock has reacted negatively to the company's performance trajectory, plunging 34.88% over the past year and currently trading 39.95% below its 52-week high of ₹373.00.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Press Release / Media Release
07-Feb-2026 | Source : BSEPress release on financial performance for Q3FY26
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
06-Feb-2026 | Source : BSEAs per attachment
Outcome Of The Board Meeting Held On February 6 2026.
06-Feb-2026 | Source : BSEAs per attachment
Corporate Actions 
No Upcoming Board Meetings
DMCC Speciality Chemicals Ltd has declared 25% dividend, ex-date: 22 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 3 FIIs (0.13%)
Laxmikumar Narottam Goculdas (36.27%)
Girish Gulati (huf) (2.28%)
33.27%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 27.81% vs 46.58% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -21.60% vs 2,438.71% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024
Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 31.97% vs 26.15% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 30.76% vs 158.59% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024
YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024






